Mental health conditions
New classification system to diagnose SSRI withdrawal proposed
Researchers propose new model to help doctors withdrawing SSRI therapy.
Source: Charles Bach / Science Photo Library
Selective serotonin reuptake inhibitors (SSRIs) are an important treatment for depression and other mental health conditions. However, after long-term treatment it can be difficult to distinguish between withdrawal symptoms and a relapse of the original illness.
Researchers, writing in Psychotherapy and Psychosomatics (2015;84:63–71), have proposed a new classification system to help physicians diagnose different types of withdrawal symptoms.
The recommendations are based primarily on a concurrently published systematic review of 23 studies and 38 case reports.
The researchers highlight three categories of SSRI and serotonin-noradrenaline reuptake inhibitor (SNRI) withdrawal symptoms — new withdrawal symptoms, rebound and persistent post-withdrawal disorder — and propose diagnostic criteria to distinguish them according to their type, onset and severity.
The system should help doctors more effectively find a minimum therapeutic dose when withdrawing or reducing SSRI therapy, the researchers say, while avoiding prolonged treatment and overmedication.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20200148
Recommended from Pharmaceutical Press